Patients with inflammatory bowel disease who had three or four specific acetyltransferases in their gut microbiota had a threefold higher risk for 5-ASA treatment failure.
Digestive issues like bloating and cramping are common, but if you have inflammatory bowel disease (IBD), your symptoms are more severe. IBD symptoms can even be life-threatening. There is no [.]